Atlas Trials

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

Clinical trial NCT01469572 · COMPLETED

Trial details

NCT number
NCT01469572
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2011-12-01
Primary completion
2018-10-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.